期刊文献+

转染HPV16E6基因人树突状细胞疫苗的制备及生物学特性 被引量:2

Vaccine preparation of dendritic cell transfected with HPV16E6 antigen gene and its biological characteristics
下载PDF
导出
摘要 目的制备来源于人外周血并转染HPV16E6基因的树突状细胞(DC)疫苗,检测其细胞形态、分子表型及诱导的免疫效应。方法细胞因子扩增人外周血DC,Lipofectamine转染HPV16E6制备DC疫苗。动态形态学观察,免疫细胞化学及流式细胞术检测分子表达,体外诱导并测定CTL活性。结果转染DC呈形态迥异的多突起状,其E6蛋白、CD80、CD86和CD83分子的表达率依次为47.3%、82.5%、79.8%和85.7%,诱导杀伤Caski细胞的活性明显高于对照组(P<0.01)。结论转染DC疫苗保持了功能成熟DC的形态特征,且内源性表达E6蛋白,能诱导高效的特异性抗肿瘤免疫应答。 Objective:To prepare the vaccine of DC derived from human peripheral blood and transfected with HPV16E6 antigen gene, and to detect its morphological character,surface marker and immunological effect. Methods:DC-enriched populations were prepared from human peripheral blood mononuclear cell(PBMC) with the combination of rhGM-CSF,rhlL-4 and rhTNF-α. The plasmid containing HPV16E6 gene was transfected into DC with lipofectamine. The morphology of DC was observed dynamically, and the expression of surface markers of DC vaccine could be detected using immuno-cytochemical staining and flow cytometry. MTT assay was applied to detect the activity of CTL in vitro. Results:Tile transfected DC had typical morphologic and phenotypic characteristics, and expressed E6 protein 47.3% , CD80 82.5% , CD86 79. 8% and CD83 85.7%. The killing activities of CTL to Caski cells induced by transfeeted DC were higher evidently than that of control groups( P 〈 0. 01 ). Conclusion: DC transfected with HPV16E6 gene can sustain the morphology and phenotype of mature DC, endogenously express E6 protein, and induce specific antitumor immune CTL response in vitro.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2006年第11期1032-1035,1040,共5页 Chinese Journal of Immunology
基金 广东省高校自然科学基金项目(Z02040)资助
关键词 树突状细胞 E6基因 基因转染 脂质体 CASKI细胞 Dendritic cell E6 gene Gene transfection Lipofectamine Caski cells
  • 相关文献

参考文献15

  • 1Nestle F O,Farkas A,Conrad C.Dendritic-cell-based therapeutic vaccination against cancer[J].Curr Opin Immunol,2005;17(2):163-169.
  • 2Indrova M,Reinis M,Bubenik J et al.Immunogenicity of dendritic cell-based HPV16 E6/E7 peptide vaccines:CTL activation and protective effects[J].Folia Biol(Praha),2004;50(6):184-193.
  • 3Mendoza L,Bubenik J,Simova J et al.Prophylactic,therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours[J].Int J Oncol,2003;23(1):243-247.
  • 4Nataliya Tkachenko,Kamila Wojas.Generation of dendritic cells from human peripheral blood monocytes-comparison of different culture media[J].Folia Histochem Cytobiol,2005;43(1):25-30.
  • 5Heiser A,Coleman D,Danmull J et al.Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors[J].J Clin Invest,2002;109(3):409-417.
  • 6Hegmans J P,Hemmes A,Aerts J G et al.Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells[J].Am J Respir Crit Care Med,2005;171 (10):1168-1177.
  • 7Hanks B A,Jiang J,Singh R A et al.Tumor-dendritic cell fusion as a basis for cancer immunotherapy[J].Nat Med,2005;11(2):130-137.
  • 8Haensen G,Krause U,Becker A et al.Tumor hypoxia,p53,and prognosis in cervical cancers[J].Int J Radiation Oncology Biol Phys,2001;50(4):865-872.
  • 9Santin A D,Bellone S,Palmieri M et al.Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix[J].Gynecol Oncol,2003;89(2):271-280.
  • 10Adams M,Navabi H,Jasani B et al.Dendritic cell(DC)based therapy for cervical cancer:use of DC pulsed tumor lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly[J].Vaccine,2003;21(7-8):787-790.

同被引文献20

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部